FDA product code QJI: Interoperable Automated Glycemic Controller

QJI is the FDA product code for interoperable automated glycemic controller. It is a Class II device, regulated under 21 CFR 862.1356 and reviewed by the Clinical Chemistry panel. FDA has cleared 24 510(k) submissions under QJI, 23 in the last five years, from 12 different applicants. The average 510(k) review took 163 days (median 84); 124 days on average over the last three years. 1 De Novo request was granted under it.

Definition

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Classification

FieldValue
Device nameInteroperable Automated Glycemic Controller
Device classClass II
Regulation21 CFR 862.1356
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for QJI

YearClearancesAvg. review days
20201111
20222294
20234332
20244171
20255139
2026863

Compare with all 510(k) review times · Search every QJI clearance

Top QJI applicants

ApplicantClearancesLatest
Insulet Corporation62026-06-29
Tandem Diabetes Care, Inc.52026-04-24
Beta Bionics, Inc.32026-09-11
Medtronic Minimed, Inc.22026-01-14
Deka Research and Development Corp.12026-10-15

7 more applicants have QJI clearances. See the full list in Caduvo.

Most recent QJI clearances

510(k)ApplicantDeviceDecision dateReview days
K262576Deka Research and Development Corp.twiist Loop Algorithm2026-10-1580
K261896CamDiabiOS CamAPS FX2026-09-16100
K262763Beta Bionics, Inc.iLet Dosing Decision Software2026-09-1138
K261962Medtronic MiniMedSmartGuard Technology; Predictive Low Glucose Technology2026-07-0928
K261461Insulet CorporationOmnipod 6 algorithm2026-06-2956

Recalls for QJI devices

FDA recall records list no recalls for product code QJI.

Frequently asked questions

What is FDA product code QJI?

QJI is the FDA product code for interoperable automated glycemic controller. It is a Class II device, regulated under 21 CFR 862.1356 and reviewed by the Clinical Chemistry panel.

What device class is QJI?

Class II, regulation 21 CFR 862.1356. Typical premarket route: 510(k).

How long does a 510(k) take for product code QJI?

Across 24 cleared submissions the average was 163 days from receipt to decision (median 84).

Which companies have the most QJI clearances?

Insulet Corporation (6); Tandem Diabetes Care, Inc. (5); Beta Bionics, Inc. (3); Medtronic Minimed, Inc. (2); Deka Research and Development Corp. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times